Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study

Table 1 Incidence of diabetes mellitus according to patient baseline characteristics

Baseline characteristics	Category	Total	Number of patients with diabetes mellitus	PYFU	Incidence per 1000 PYFU	95% CI	P value*
Total		199,707	8383	763,666	10.98	10.74–11.21
Fiscal year of registration	2007	41,537	2852	248,385	11.48	11.07–11.91	< 0.001
	2008	34,100	1729	165,818	10.43	9.95–10.93
	2009	28,872	1343	119,249	11.26	10.68–11.88
	2010	26,026	916	89,424	10.24	9.60–10.93
	2011	24,270	699	66,880	10.45	9.70–11.26
	2012	22,861	443	46,229	9.58	8.73–10.52
	2013	22,041	401	27,682	14.49	13.14–15.98
Sex	Female	91,407	3604	381,552	9.45	9.14–9·76	< 0.001
Sex	Male	108,300	4779	382,114	12.51	12.16–12.87
Age (years)	18–34	87,948	2076	354,196	5.86	5.61–6.12	< 0.001
	35–44	74,610	3521	288,739	12.19	11.80–12.60
	45–59	33,154	2428	110,286	22.02	21.16–22.91
	≥60	3995	358	10,444	34.28	30.90–38.02
History of hepatitis C infection	No	198,299	8327	760,649	10.95	10.71–11·18	< 0.001
History of hepatitis C infection	Yes	1408	56	3017	18.56	14.28–24.12
Variables with more than 20% missing data
Body mass index (kg/m²)	< 25	59,249	2154	218,284	9.87	9.46–10.29	< 0.001
Body mass index (kg/m²)	≥25	7296	509	29,241	17.41	15.96–18.99
Triglycerides (mg/dl)	< 200	9252	289	30,352	9.52	8.48–10.69	0.0021
Triglycerides (mg/dl)	≥200	2511	111	8280	13.41	11.13–16.15
Absolute CD4 cell count (cells/mm³)	≥200	36,877	1283	144,795	8.86	8.39–9.36	< 0.001
Absolute CD4 cell count (cells/mm³)	< 200	58,570	2114	183,322	11.53	11.05–12.03
Nadir CD4 cell count (cells/mm³)	≥200	36,877	1279	144,522	8.85	8.38–9.35	< 0.001
Nadir CD4 cell count (cells/mm³)	< 200	58,671	2118	183,721	11.53	11.05–12.03

ISSN: 1471-2458